<?xml version="1.0" encoding="UTF-8"?>
<p>GS-561937 (also designated referred to as GS1) and GS-5806 have been proposed as FPI treatments for bovine and human RSV respectively; they have the same antiviral mechanism of action and differ only in the substitution of a methyl group for a Cl in the bovine version.</p>
